CH681625A5 - - Google Patents

Download PDF

Info

Publication number
CH681625A5
CH681625A5 CH2577/90A CH257790A CH681625A5 CH 681625 A5 CH681625 A5 CH 681625A5 CH 2577/90 A CH2577/90 A CH 2577/90A CH 257790 A CH257790 A CH 257790A CH 681625 A5 CH681625 A5 CH 681625A5
Authority
CH
Switzerland
Prior art keywords
nap
nsa
neutrophil
peptide
platelets
Prior art date
Application number
CH2577/90A
Other languages
German (de)
English (en)
Inventor
Marco Baggiolini
Kenneth John Clemetson
Alfred Walz
Original Assignee
Sandoz Ag
Kocher Theodor Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828728A external-priority patent/GB8828728D0/en
Priority claimed from GB898909681A external-priority patent/GB8909681D0/en
Application filed by Sandoz Ag, Kocher Theodor Inst filed Critical Sandoz Ag
Publication of CH681625A5 publication Critical patent/CH681625A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CH2577/90A 1988-12-08 1989-11-17 CH681625A5 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888828728A GB8828728D0 (en) 1988-12-08 1988-12-08 Neutrophil-stimulating activity i
GB898909681A GB8909681D0 (en) 1989-04-27 1989-04-27 Neutrophil-stimulating activity 1

Publications (1)

Publication Number Publication Date
CH681625A5 true CH681625A5 (cg-RX-API-DMAC10.html) 1993-04-30

Family

ID=26294713

Family Applications (1)

Application Number Title Priority Date Filing Date
CH2577/90A CH681625A5 (cg-RX-API-DMAC10.html) 1988-12-08 1989-11-17

Country Status (19)

Country Link
US (1) US5759533A (cg-RX-API-DMAC10.html)
JP (1) JP3051160B2 (cg-RX-API-DMAC10.html)
KR (1) KR910700260A (cg-RX-API-DMAC10.html)
AU (1) AU634508B2 (cg-RX-API-DMAC10.html)
BE (1) BE1003636A4 (cg-RX-API-DMAC10.html)
CA (1) CA2004685A1 (cg-RX-API-DMAC10.html)
CH (1) CH681625A5 (cg-RX-API-DMAC10.html)
DK (1) DK188690A (cg-RX-API-DMAC10.html)
ES (1) ES2047458A6 (cg-RX-API-DMAC10.html)
FI (1) FI903931A7 (cg-RX-API-DMAC10.html)
FR (1) FR2640142B1 (cg-RX-API-DMAC10.html)
GB (1) GB2231872B (cg-RX-API-DMAC10.html)
GR (1) GR1000455B (cg-RX-API-DMAC10.html)
IL (1) IL92557A0 (cg-RX-API-DMAC10.html)
NL (1) NL8921262A (cg-RX-API-DMAC10.html)
NZ (1) NZ231652A (cg-RX-API-DMAC10.html)
PT (1) PT92509A (cg-RX-API-DMAC10.html)
SE (1) SE9002589L (cg-RX-API-DMAC10.html)
WO (1) WO1990006321A1 (cg-RX-API-DMAC10.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐2
EP0513201A1 (en) * 1990-02-01 1992-11-19 University Of South Florida Leukocyte-derived growth factor
US6673893B1 (en) 1990-02-01 2004-01-06 University Of South Florida Leukocyte derived growth factor 2
WO1993001826A1 (en) * 1991-07-19 1993-02-04 East Carolina University Method of treating asthma
AU3071492A (en) * 1991-11-15 1993-06-15 University Of Pennsylvania Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
CA2153409A1 (en) * 1993-01-07 1994-07-21 Gary R. Grotendorst Leukocyte derived growth factors
US5578569A (en) * 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US5912232A (en) * 1994-09-23 1999-06-15 Board Of Regents Of The University Of Nebraska Anti-inflammatory polypeptide antagonists of human I1-8
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
US6290948B1 (en) * 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
WO1999015548A2 (en) * 1997-09-25 1999-04-01 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
EP2110436B1 (en) * 2000-03-07 2013-01-30 Japan Tobacco Inc. Polypeptides having neutrophil stimulating activity
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
ATE518884T1 (de) 2002-05-01 2011-08-15 Human Genome Sciences Inc Spezifisch an chemokin beta-4 bindende antikörper
US7177246B2 (en) * 2003-09-12 2007-02-13 Hewlett-Packard Development Company, L.P. Optical disk drive focusing apparatus using sum signal
MX361929B (es) 2010-11-19 2018-12-19 Eisai R&D Man Co Ltd Star Anticuerpos anti-ligando de quimiocina cc 20 (ccl20) neutralizantes.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
JP3051160B2 (ja) * 1988-12-08 2000-06-12 ノバルティス・アクチエンゲゼルシャフト 好中球活性化ペプチド‐2

Also Published As

Publication number Publication date
DK188690D0 (da) 1990-08-07
FR2640142B1 (fr) 1994-09-23
AU4655689A (en) 1990-06-26
GB2231872A (en) 1990-11-28
PT92509A (pt) 1990-06-29
NZ231652A (en) 1993-02-25
GB9011468D0 (en) 1990-08-29
FI903931A0 (fi) 1990-08-08
NL8921262A (nl) 1990-11-01
IL92557A0 (en) 1990-08-31
FI903931A7 (fi) 1990-08-08
AU634508B2 (en) 1993-02-25
FR2640142A1 (fr) 1990-06-15
GR1000455B (el) 1992-07-30
US5759533A (en) 1998-06-02
WO1990006321A1 (en) 1990-06-14
KR910700260A (ko) 1991-03-14
JPH03503767A (ja) 1991-08-22
DK188690A (da) 1990-08-07
GB2231872B (en) 1992-07-22
SE9002589D0 (sv) 1990-08-07
GR890100810A (en) 1991-03-15
BE1003636A4 (fr) 1992-05-12
CA2004685A1 (en) 1990-06-08
SE9002589L (sv) 1990-08-07
ES2047458A6 (es) 1994-02-16
JP3051160B2 (ja) 2000-06-12

Similar Documents

Publication Publication Date Title
DE69028671T2 (de) Löslisches extrazellulares Fragment des menschlischen IFN-beta 2/IL-6-Rezeptors, seine Herstellung und diesen Fragment enthaltende pharmazeutische Mischung
DE69226592T2 (de) Neue neutrophilaktivierende Faktoren
DE69014474T2 (de) Antikörper gegen TNF-Bindungsprotein I und deren F(ab)-Fragmente.
DE69519454T2 (de) Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
DE69017753T3 (de) Tumor-Nekrosefaktor-Bindungsprotein II, seine Reinigung und spezifische Antikörper
DE69330087T2 (de) System zur lokalisierung und kommunikation mit mobilen fahrzeugen
DE69520088T3 (de) Interferon-gamma-induzierendes Polypeptid monoklonal Antikörper, und Zusammensetzung für Interferon-gamma gebunden Krankheiten
DE69434053T2 (de) Verkürzter keratinocytenwachstumsfaktor(kgf)mit erhöhter biologischer aktivität
EP0393438B1 (de) TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs
DE3650088T2 (de) Inhibin und dessen reinigung.
DE69032600T3 (de) Rekombinanter abkömmling des menschlichen faktors iii
DE3855802T2 (de) Von Makrophagen abstammender Entzündungsvermittler(MIP-1-alpha et MIP-1-beta)
EP0538300B1 (de) O-glycosyliertes ifn-alpha
DE68910354T2 (de) Menschliches mutantes Angiogenin (Angiogenese-Faktor mit überlegener Angiogenin-Aktivität), Gene dafür und Methode zur Expression.
US5759533A (en) Neutrophil-activating peptide-2
DE69823218T2 (de) Aminoterminal verkürztes mcp-2 als chemokin antagonist
DE69032251T2 (de) Il-1, dessen biologische aktivität inhibiert ist
DE69128564T2 (de) Extrazelluläre form des menschlichen fibroblasten wachstumsfaktorrezeptors
DE60103078T2 (de) Chemokin mutanten zur behandlung multipler sklerose
DE69033756T2 (de) Gene, die für MACIF Proteine kodieren, Expressionsvektoren mit diesem Genen, und Transformantenzellen mit diesem Proteinen
EP1959013B1 (de) Humanes zirkulierendes Virus inhibierendes Peptid (VIRIP) und seine Verwendung
DE69931784T2 (de) Chemotaxishemmendes protein von staphylococcus aureus (chips) und dessen verwendung
DE69132682T2 (de) Zellwachstumsinhibitoren
DE69029040T2 (de) Megakaryocytopoietischer faktor
DE69533905T2 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased